BOUNDLESS BIO, INC. Depreciation
BOUNDLESS BIO, INC. (BOLD) reported Depreciation of $528.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued
us-gaap:Depreciation · last filed 2024-08-12
- BOUNDLESS BIO, INC. depreciation for the quarter ending 2024-06-30 was $265.00K, a 11.34% increase year-over-year.
- BOUNDLESS BIO, INC. depreciation for the quarter ending 2024-03-31 was $263.00K, a 10.97% increase year-over-year.
- BOUNDLESS BIO, INC. depreciation for the quarter ending 2023-06-30 was $238.00K.
- BOUNDLESS BIO, INC. depreciation for the quarter ending 2023-03-31 was $237.00K.
| Period end | Depreciation 3 month | Depreciation 6 month |
|---|---|---|
| 2024-06-30 | $265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $528.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $263.00K 10-Q · filed 2024-05-13 | |
| 2023-06-30 | $238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $475.00K 10-Q · filed 2024-08-12 |
| 2023-03-31 | $237.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |